Rodrigo C. Fernández-Valdivia

Prof. Rodrigo C. Fernández-Valdivia

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAmnah Sharif
Amnah Sharif
ASAnn Shaji
Ann Shaji
May ChammaaMay Chammaa
May Chammaa
EPEileen Pawlik
Eileen Pawlik
RFRodrigo C. Fernández-Valdivia
Rodrigo C. Fernández-Valdivia
The evolutionarily-conserved Notch signaling pathway plays critical roles in cell communication, function and homeostasis equilibrium. The pathway serves as a cell-to-cell juxtaposed molecular transducer and is crucial in a number of cell processes including cell fate specification, asymmetric cell division and lateral inhibition. Notch also plays critical roles in organismal development, homeostasis, and regeneration, including somitogenesis, left-right asymmetry, neurogenesis, tissue repair, self-renewal and stemness, and its dysregulation has causative roles in a number of congenital and acquired pathologies, including cancer. In the lung, Notch activity is necessary for cell fate specification and expansion, and its aberrant activity is markedly linked to various defects in club cell formation, alveologenesis, and non-small cell lung cancer (NSCLC) development. In this review, we focus on the role this intercellular signaling device plays during lung development and on its functional relevance in proximo-distal cell fate specification, branching morphogenesis, and alveolar cell determination and maturation, then revise its involvement in NSCLC formation, progression and treatment refractoriness, particularly in the context of various mutational statuses associated with NSCLC, and, lastly, conclude by providing a succinct outlook of the therapeutic perspectives of Notch targeting in NSCLC therapy, including an overview on prospective synthetic lethality approaches.

28 June 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
May ChammaaMay Chammaa
May Chammaa
AMAgnes Malysa
Agnes Malysa
CRCarlos Redondo
Carlos Redondo
HJHyejeong Jang
Hyejeong Jang
WCWei Chen
Wei Chen
RFRodrigo C. Fernández-Valdivia
Rodrigo C. Fernández-Valdivia

22 April 2026 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
SZSteven P. Zielske
Steven P. Zielske
RFRodrigo C. Fernández-Valdivia
Rodrigo C. Fernández-Valdivia

12 October 2018 in Journal of Cellular Physiology
Verified
Journal Article
Open access
PDF file
MCMay Chammaa
May Chammaa
AMAgnes Malysa
Agnes Malysa
CRCarlos Redondo
Carlos Redondo
HJHyejeong Jang
Hyejeong Jang
WCWei Chen
Wei Chen
RFRodrigo C. Fernández-Valdivia
Rodrigo C. Fernández-Valdivia
Cover: The cover image, by Chammaa et al., is based on Original Research Article, RUMI is a novel negative prognostic marker and therapeutic target in non‐small‐cell lung cancer, DOI: 10.1002/jcp.26858.

1 January 2019
Verified
Journal Article
Closed access
RFRodrigo C. Fernández-Valdivia
Rodrigo C. Fernández-Valdivia
May ChammaaMay Chammaa
May Chammaa
DGDennis Goebel
Dennis Goebel
IJIvy John
Ivy John
RBRafic Beydoun
Rafic Beydoun